Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2002
10/31/2002US20020161006 1,4-dihydropyridine compounds as bradykinin antagonists
10/31/2002US20020161004 Antiinflammation agents
10/31/2002US20020161001 Heterocyclic compounds, which are inhibitors of the enzyme DPP-IV
10/31/2002US20020160999 Treatment of diseases or disorders of the central nervous system
10/31/2002US20020160997 Novel indole derivatives
10/31/2002US20020160990 Esters with a polyunsaturated fatty acid, for example, eicosapentaenoic acid, beta-sitosterol ester; lowering serum cholesterol levels
10/31/2002US20020160987 Novel 4-dedimethylaminotetracycline derivatives
10/31/2002US20020160984 For example, 2,3-dihydro-1H-benz(de)isoquinolin-1-one; treating diabetes, cancer, radiosensitizing tumor cells, cardiovascular disorders, septic shock, inflammatory bowel disease, senescent cells
10/31/2002US20020160982 Modafinil compound and cyclodextrin mixtures
10/31/2002US20020160974 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays
10/31/2002US20020160961 Thyrotropin-Releasing Hormone (TRH) and a peptide of given formula, such as ipamorelin; treatment of wasting
10/31/2002US20020160955 Protein variants
10/31/2002US20020160938 At least one is a human or animal insulin analogue; coupled together with a diacid such as by reacting with suberic acid, bis(N-hydroxysuccinimidyl) ester
10/31/2002US20020160499 For use in diagnosis, prophylaxis, and therapy of disorders associated with expression of serine carboxypeptidase
10/31/2002US20020160484 Central nervous system disorders therapy; genetic engineering
10/31/2002US20020160478 Short peptides which selectively modulate the activity of protein kinases
10/31/2002US20020160394 Regulation of transthyretin to treat obesity
10/31/2002US20020160044 Liver selective drug therapy
10/31/2002US20020160008 Treatment of diabetes
10/31/2002US20020160000 PD-1, a receptor for B7-4, and uses therefor
10/31/2002US20020159973 Administering to the patient at least one statin (HMG-Coa-reductase inhibitor) in an amount effective to modulate MHC class II (Major Histocompability complex) or CD/40(antigen) expression in the patient
10/31/2002US20020159968 A stable polyallylamine hydrochloride polymer crosslinked by epichlorohydrin
10/31/2002US20020159956 Providing a chewing gum, includes a gum center and a coating coverings, coating includes a drug designed to be delivered into systemic system of indivisual
10/31/2002US20020159951 Administering to the patient a contrast agent comprising, in an aqueous carrier, targeted vesicles formulated from a lipid or polymer, a prfluorocarbon gas, a targeting ligand, scanning the patient using ultrasound to obtain an image
10/31/2002EP0760670A4 Cellular factors that regulate the expression of genes encoding proteins involved in cholesterol homeostasis
10/31/2002DE10121217A1 6H-Oxazolo[4,5-e]indol-Derivate als nikotinische Acetylcholinrezeptor Liganden und/oder serotonerge Liganden 6H-oxazolo [4,5-e] indole derivatives as nicotinic acetylcholine receptor ligands and / or serotonergic ligands
10/31/2002DE10121215A1 Dihydro-imidazo[4,5-e]indol- und 7H-Pyrrolo[3,2-f]chinoxalin Derivate als nikotinische Acetylcholinrezeptor Liganden und/oder serotonerge Liganden Dihydro-imidazo [4,5-e] indole and 7H-pyrrolo [3,2-f] quinoxaline derivatives as nicotinic acetylcholine receptor ligands and / or serotonergic ligands
10/31/2002CA2807478A1 Use of follistatin to increase muscle mass
10/31/2002CA2445888A1 Chiral, broad-spectrum antibacterial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation and compositions
10/31/2002CA2445255A1 Vhh single heavy chain antibody and a method for its preparation in a mammal
10/31/2002CA2444675A1 Secreted proteins
10/31/2002CA2444602A1 Anti-obesity polypeptides
10/31/2002CA2444599A1 Melanocortin receptor ligands
10/31/2002CA2444370A1 Use of radical scavenging compounds for treatment and prevention of no-dependent microcirculation disorders
10/31/2002CA2444347A1 Method for treating gout and binding uric acid
10/31/2002CA2444235A1 New polynucleotides and polypeptides of the ifn.alpha.-17 gene
10/31/2002CA2444095A1 Heterocyclyloxy-, -thioxy- and -aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
10/31/2002CA2444028A1 Methods of treating syndrome x with aliphatic polyamines
10/31/2002CA2443946A1 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
10/31/2002CA2443600A1 Heterocyclyldicarbamides as caspase inhibitors
10/31/2002CA2443373A1 New polynucleotides and polypeptides of the erythropoietin gene
10/30/2002EP1252333A2 Methods and materials relating to cd84-like polypeptides and polynucleotides
10/30/2002EP1252189A2 Novel human nucleic acid molecules and polypeptides encoding cation channels
10/30/2002EP1252188A2 G-protein coupled receptors
10/30/2002EP1252170A2 Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate
10/30/2002EP1252164A1 Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizine-5-yl acetic acid
10/30/2002EP1252158A1 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes
10/30/2002EP1252150A1 Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same
10/30/2002EP1252144A1 Substituted glutarimides and use thereof il-12 production inhibitors
10/30/2002EP1252143A1 Method for preparing alpha-sulfonyl hydroxamic acid derivatives
10/30/2002EP1252137A1 Palatable arginine compounds and uses thereof for cardiovascular health
10/30/2002EP1252133A2 Pharmaceutical compounds
10/30/2002EP1251873A1 Antagonist of th-1 immuneresponse inducing cytokine for the treatment of autoimmune diseases
10/30/2002EP1251865A1 Cyclic peptides as potent and selective melanocortin-4 receptor antagonists
10/30/2002EP1251862A1 Ophthalmic compositions for treating ocular hypertension
10/30/2002EP1251861A2 Physiologically active compositions of basidiomycotina and araliaceae extracts
10/30/2002EP1251857A1 Pharmaceutical parenteral composition containing a bisphosphonate
10/30/2002EP1251855A1 Selective estrogen receptor modulators in combination with estrogens
10/30/2002EP1251843A1 Compositions for delivery of a cortisol antagonist
10/30/2002EP1251831A1 Pharmaceutical compositions comprising a hmg coa reductase inhibitor
10/30/2002EP1251829A1 Electrospun pharmaceutical compositions
10/30/2002EP1251738A1 Novel diphenylethylene compounds
10/30/2002EP1137416B1 Use of long-chain n-alkyl derivatives of deoxynojirimycin for the manufacture of a medicament for the treatment of glycolipid storage diseases
10/30/2002EP0851763B1 Method and composition for enhanced parenteral nutrition
10/30/2002EP0793660B1 2-substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
10/30/2002EP0775126B1 Hypolipidemic 1,4-benzothiazepine-1,1-dioxides
10/30/2002CN1377424A Methods of reparing tandemly repeated DNA sequences and extending cell life-span using nuclear transfer
10/30/2002CN1377405A Personal care articles
10/30/2002CN1377366A 5-hydroxysapogenin derivatives with anti-dementia activity
10/30/2002CN1377363A Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof
10/30/2002CN1377356A Certain alkylene diamine-substituted heterocycles
10/30/2002CN1377355A Amino substituted pyrazolo [1,5-2]-1,5-pyrimidines and pyrazolo [1,5-2]-1,3, 5-triazines
10/30/2002CN1377354A Certain alkylene diamine-substituted pyrazolo [1,5-a]-1,5-pyrimidines and pyrazolo [1,5-a]-1,3,5-triazines
10/30/2002CN1377349A Quiunclidine compounds and drugs containing the same as the active ingredient
10/30/2002CN1377346A Z-pyrazoline-5-ones
10/30/2002CN1377344A Inhibitor of cysteinyl aspartic acid proteinase
10/30/2002CN1377278A Prevention and treatment of amyloidogenic disease
10/30/2002CN1377273A Antiobestic agents
10/30/2002CN1377268A Cell adhesion inhibitors
10/30/2002CN1377266A Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion
10/30/2002CN1377260A Methods and compounds for inhibiting amyloid deposits
10/30/2002CN1377238A Composition comprising casein protein and whey protein
10/30/2002CN1377235A Nutritional compositions which contain non-digestible polysaccharides and use thereof to reduce transport through tight junctions
10/30/2002CN1376717A Fatty diacylamino acid insulin as oral medicine for treating diabetes and its synthesizing process
10/30/2002CN1376664A Propynyl or diene diaryl compounds
10/30/2002CN1376495A Chinese medicine for treating diabetes and its complication
10/30/2002CN1376471A Soft capsule 'Shaganling'
10/30/2002CN1376399A Hypoglycmic-hypolipemic bean
10/30/2002CN1093405C Defatting tea
10/30/2002CA2383469A1 Treatment of t-cell mediated diseases
10/29/2002US6472505 Treatment of physiological conditions capable of being modulated by agonist or antagonist activity on parathyroid hormone receptors
10/29/2002US6472421 Methods for treating, preventing, and reducing the risk of the onset of alzheimer's disease using an HMG CoA reductase inhibitor
10/29/2002US6472418 Non-peptide NK1 receptors antagonists
10/29/2002US6472412 Compounds as PDE IV and TNF inhibitors
10/29/2002US6472402 Aminoalkyl substituted 5,6,7,8-Tetrahydro-9H-Pyridino [2,3-B]indole derivatives
10/29/2002US6472401 Administering an antiallergen of loratadine or metabolite of loratadine, desloratadine; migraines, stroke, orthostatic hypotension, gastrointestinal stasis, nausea, dizziness and jet lag; also psychological disorders; 5-ht7 receptors
10/29/2002US6472400 Advanced gylcation end-product intermediaries and post-Amadori inhibition
10/29/2002US6472398 Spiropiperidine derivatives as melanocortin receptor agonists
10/29/2002US6472394 MCH antagonists and their use in the treatment of obesity
10/29/2002US6472378 Compositions and methods for treatment of mitochondrial diseases
1 ... 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 ... 1298